Cancer Vaccines
Geron clarifies license rights for cancer vaccines
Published in Cancer Weekly, February 28th, 2006
On July 15, 2005, Geron announced a worldwide, exclusive license and collaboration agreement with Merck & Co., Inc., (MRK) which includes the grant of rights to Merck to develop anticancer therapies that target telomerase utilizing Merck's vaccine platforms. The agreement also grants Merck an exclusive option to Geron's dendritic cell-based telomerase vaccine. On February 1, 2006, Pharmexa, A/S, Horsholm, Denmark, which acquired GemVax in 2005, issued an announcement describing studies it intends to pursue with a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-02-28)
More Articles from Cancer Weekly
- Bladder Cancer
Polymorphism in hGPX1 gene may be used as marker for bladder cancer recurrence - Colon Cancer
Disease-free survival after 3-year follow-up proposed as end point for colon cancer clinical trial - Glioma
Dihydroartemisinin enhanced radiosensitivity of human glioma cells - Leukemia
NS-187 proposed as novel agent for imatinib-resistant leukemia - Lung Cancer
Altered EGFR signaling implicated in genetic susceptibility to lung cancer - Acute Myeloid Leukemia
Impaired C/EBP alpha function contributes directly to AML development - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
